NVDA Hits Record $6 Trillion Valuation After 20% Rally; Peak Debate Intensifies
NVIDIA shares surged 20 percent over seven days and touched $6 trillion market cap as investors plow into AI chipmakers on sustained data center capex. News of Jensen Huang in Beijing and H200 approval fueled the rally, but short-seller Mark Burry signals contrarian positioning as valuation extremes invite profit-taking risks.
RKey facts
- NVDA surged 20% in seven days to approach $6 trillion market cap
- Jensen Huang attended Beijing summit; US approved H200 sales to 10 Chinese firms
- Michael Burry hinted at peak-cycle warning with 'hunting season' comment
- Retail investor 'all-in' sentiment visible on social media trading platforms
What's happening
NVIDIA's stock extended its extraordinary run, climbing 20 percent in seven days and approaching a $6 trillion market valuation. The surge reflects unabated conviction among growth investors that AI infrastructure demand will sustain for years and that NVIDIA's dominant GPU architecture justifies massive capex multiples. New catalysts included Jensen Huang's appearance in Beijing at the Trump-Xi summit and news that the US government approved H200 chip sales to 10 Chinese companies, both read as fresh greenlight signals for NVIDIA's China revenue.
Yet the sheer pace of gains and the valuation math are prompting tactical skepticism. Legendary short-seller Michael Burry tweeted 'Where is Burry's stop loss? It's hunting season,' a reference to liquidation cascades in momentumThe empirical fact that winners keep winning over the medium term. crowded positions. Separately, retail traders have begun aping into NVIDIA calls, with social media commentary suggesting some retail accounts have switched to fully-leveraged bets on the stock. Market history suggests that when 'normal' retail investors openly discuss going all-in on a single mega-cap, the momentum phase is often nearing its end.
The narrative tension is stark. On one side, the memory-constraint story and Asia-Pacific data center expansion genuinely support sustained AI capex. On the other, NVIDIA's stock has already incorporated five years of growth optionality. A modest surprise on gross margin, manufacturing capacity, or a pivot in customer behavior (e.g., hyperscalers building in-house chips to reduce NVIDIA dependency) would trigger sharp mean reversion. The stock's options market is pricing elevated volatility, and recent earnings delivered the goods, but at these valuations, the bar for 'surprise' is extraordinarily high.
Cross-asset implications are real. A sharp NVDA correction would pressure the Nasdaq and growth equities broadly, given NVDA's weighting. Semiconductor peer stocks (AMD, Broadcom, ARM) would likely follow lower. Conversely, a continuation above $6 trillion could sustain the mega-cap concentration narrative that has pressured Russell 2000 and small-cap performance, potentially exacerbating breadth concerns in the broader market.
What to watch next
- 01NVDA technical resistance at $231 and $240 levels: next sessions
- 02NVDA earnings date for next quarter earnings surpriseDifference between actual earnings and analyst consensus. risk
- 03Competitor announcements on in-house chip development: next 6 months
- PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VirTra, Inc. - VTSI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of VirTra, Inc. ("VirTra" or the "Company") (NASDAQ: VTSI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
9m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Matrix Service Company - MTRX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Matrix Service Company ("Matrix" or the "Company") (NASDAQ: MTRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
34m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BayCom Corp - BCML
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BayCom Corp ("BayCom" or the "Company") (NASDAQ: BCML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forward Air Corporation - FWRD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Forward Air Corporation ("Forward Air" or the "Company") (NASDAQ: FWRD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veritone, Inc. - VERI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veritone, Inc. ("Veritone" or the "Company") (NASDAQ: VERI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. ("Sanara" or the "Company") (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
1h ago
Related coverage
- U.S. Approves NVIDIA H200 Chip Sales to China, Easing AI Trade TensionsTech & AI··0 mentions
- Cisco Signals AI Networking Buildout Expanding Into Switches, Optics; CSCO Up on Infrastructure BreadthTech & AI··0 mentions
- Cerebras IPO Soars 89% on First Day; AI Chipmaker Raises $5.55B in Largest Tech IPO of YearTech & AI··0 mentions
- US Approves NVDA H200 Sales to 10 Chinese Companies, Easing Supply ConstraintsTech & AI··0 mentions
More about $NVDA
- AI Rally Leaves 75% of Active Managers Behind as Index Concentration Widens·Equities US
- Cerebras Systems IPO Surges 89%, Raises $5.55 Billion in Year's Largest Tech Offering·Tech & AI
- U.S. Approves NVIDIA H200 Chip Sales to China, Easing AI Trade Tensions·Tech & AI
- Top 10 US Stocks Now Drive Record Share of SPY Gains; Breadth Concerns Mount·Equities US
- Cerebras IPO Raises $5.55B, Shares Indicated Up 89% on AI Chip Appetite·Tech & AI
Live coverage of the AI semiconductor cycle — NVDA, AVGO, AMD, ASML, memory demand, capex run rates and overbought signals.